Novartis Beats Zometa Injury Suit At 2nd Circ.

Law360, New York (August 29, 2012, 8:11 PM EDT) -- The Second Circuit on Wednesday affirmed a jury win for Novartis Pharmaceuticals Corp. in a case where a widow accused its drug Zometa of causing her husband's jaw disease, ruling that expert evidence was not improperly excluded.

A federal judge did not make an error when he excluded a witness for widow Karlene Hogan from a seven-day trial, the appeals court said in a written order. The witness, Dr. Steven Brown, was offered as a plaintiff's witness just before trial, but the district court, though it...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.